Literature DB >> 32277903

Liver transplantation in patients with alcohol-related liver disease: current status and future directions.

Philippe Mathurin1, Michael R Lucey2.   

Abstract

The survival of patients with alcohol-related liver disease who receive a liver transplant has steadily improved to reach 80-85% at 1 year post-transplantation. The standard requirement for liver transplant-abstinence from alcohol for 6 months before transplantation-has been applied widely, but few data support the use of this rule as the sole criterion for selecting candidates for liver transplantation. When determining the suitability of a patient for transplantation, many liver transplant programmes now try to balance the period of abstinence against the risk of death associated with the severity of liver damage. Data accumulated since 2011 suggest that early liver transplantation (ie, transplantation without a specific period of abstinence) in patients with severe alcoholic hepatitis who do not respond to medical therapy is an effective therapeutic strategy. Further studies are needed to help refine the selection of patients with alcohol-related liver disease who have been abstinent for less than 6 months as suitable liver transplant candidates, and to improve the treatment of alcohol use disorder in those patients who have received a liver transplant.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32277903     DOI: 10.1016/S2468-1253(19)30451-0

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


  11 in total

Review 1.  Liver Biopsy in Patients With Alcohol-Associated Liver Disease With Acute-on-Chronic Liver Failure.

Authors:  Loretta Jophlin; Ashwani K Singal
Journal:  J Clin Exp Hepatol       Date:  2021-08-14

Review 2.  Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors.

Authors:  Daniel Q Huang; Philippe Mathurin; Helena Cortez-Pinto; Rohit Loomba
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-10-18       Impact factor: 73.082

Review 3.  Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.

Authors:  Alessio Aghemo; Olga P Alekseeva; Francesco Angelico; Igor G Bakulin; Natalia V Bakulina; Dmitry Bordin; Alexey O Bueverov; Oxana M Drapkina; Anton Gillessen; Elvira M Kagarmanova; Natalia V Korochanskaya; U A Kucheryavii; Leonid B Lazebnik; Maria A Livzan; Igor V Maev; Anatolii I Martynov; Marina F Osipenko; Evgenii I Sas; Antonina Starodubova; Yurii P Uspensky; Elena V Vinnitskaya; Emilia P Yakovenko; Alexey A Yakovlev
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

4.  Early Liver Transplantation: An Evolving Therapeutic Option for Alcohol-Associated Liver Disease.

Authors:  Mohamed A Elfeki; Ashwani K Singal
Journal:  J Clin Exp Hepatol       Date:  2021-10-28

5.  Plasma-Signature-Model for End-Stage Liver Disease Score to Predict Survival in Severe Alcoholic Hepatitis.

Authors:  Naoto Fujiwara; Eric Trépo; Indu Raman; Quan-Zhen Li; Delphine Degré; Thierry Gustot; Christophe Moreno; Yujin Hoshida
Journal:  Clin Gastroenterol Hepatol       Date:  2021-03-02       Impact factor: 13.576

Review 6.  Immunological mechanisms and therapeutic targets of fatty liver diseases.

Authors:  Hua Wang; Wajahat Mehal; Laura E Nagy; Yaron Rotman
Journal:  Cell Mol Immunol       Date:  2020-12-02       Impact factor: 11.530

7.  Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).

Authors:  Gianni Testino; Teo Vignoli; Valentino Patussi; Pierluigi Allosio; Maria Francesca Amendola; Sarino Aricò; Aniello Baselice; Patrizia Balbinot; Vito Campanile; Tiziana Fanucchi; Giovanni Greco; Livia Macciò; Cristina Meneguzzi; Davide Mioni; Vincenzo Ostilio Palmieri; Michele Parisi; Doda Renzetti; Raffaella Rossin; Claudia Gandin; Luigi Carlo Bottaro; Mauro Bernardi; Giovanni Addolorato; Lisa Lungaro; Giorgio Zoli; Emanuele Scafato; Fabio Caputo
Journal:  Dig Dis Sci       Date:  2021-06-17       Impact factor: 3.487

Review 8.  Moderate Alcoholic Hepatitis.

Authors:  Ana Clemente-Sánchez; Aline Oliveira-Mello; Ramón Bataller
Journal:  Clin Liver Dis       Date:  2021-05-27       Impact factor: 6.265

Review 9.  Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation.

Authors:  Juan Pablo Arab; Manhal Izzy; Lorenzo Leggio; Ramon Bataller; Vijay H Shah
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-11-01       Impact factor: 73.082

Review 10.  Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease.

Authors:  Lukas Hartl; Joshua Elias; Gerhard Prager; Thomas Reiberger; Lukas W Unger
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.